IRCT20141027019705N2 IRCT 2019-06-16 Arak University of Medical Sciences The effect of hepatobel on fatty liver The effect of hepatobel on fatty liver parameters in patients with fatty liver disorder 2019-07-10 anticipated 60 Complete https://irct.ir/trial/40128 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The present study is a simple randomized clinical trial on subjects with fatty liver. In this study, individuals are divided into two groups of drugs and placebo.The method of assigning subjects to each group is that individuals are assigned one by one to each group, Blinding description: First, it will be explained about the study to the participants. This study is a double blind study. The two groups of drug and placebo receive very similar capsules, and they do not know the contents of the capsule The statistical analyzer is not informed about the groups. 3 Patients with fatty liver. Intervention 1: Intervention group: The number of participants in this group is 30. The group has a fatty liver that receives hepatobel capsules for 6 weeks. Intervention 2: Control group: The number of participants in this group is 30. The group has a fatty liver that receives placebo capsules for 6 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is Information from people participating in a study based on ethics should remain confidential.